Long-term follow-up of mitral valve repair with Chord-X
Part of Heart & circulation clinical trials.
This study follows people who have already had a mitral valve repair using a device called the Chord-X system. Doctors will track their heart health and recovery over the next 10 years to see how well the repair holds up over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have already had a mitral valve repair using the Chord-X system (a device that fixes the heart's valve).
- Your Chord-X surgery must have happened on or after January 1, 2022.
- You must not have had any previous mitral valve surgery before the Chord-X procedure.
- You must be willing and able to attend follow-up visits for up to 10 years after your surgery.
- Your heart's pumping strength (ejection fraction) must be above 50% at the start of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new catheter-based device to fix a leaky mitral valve without open-heart surgery. It is for people whose severe mitral regurgitation puts them at high risk for traditional surgery.
This trial tests a new robotic tool that gives surgeons a sense of touch during mitral valve repair. If you have a severe leak in your mitral valve and are a good candidate for minimally invasive surgery, this study may offer a way to fix it using the da Vinci robot.
This study keeps track of people who had NeoChord treatment to help understand how well it works in everyday care. You may be included if you had a certain type of mitral valve leakage (regurgitation) and the procedure happened after 2016.
This study tests a new device to fix a leaky mitral valve without open-heart surgery. It is for people with severe symptoms who are too high-risk for traditional surgery. The procedure uses a clip to help the valve close better.
This study tests a new device called the MRace implant that is designed to repair a leaky mitral valve without open-heart surgery. It may help people with severe leakage who are at high risk for traditional surgery.
This trial tests a new device called MRace that may fix a leaky mitral valve without open-heart surgery. It's for people whose valve leaks severely and who can't have standard surgery due to other health issues.
Hear when a new Mitral Regurgitation (MR) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.